Sven Nylander

3.3k total citations
52 papers, 2.6k citations indexed

About

Sven Nylander is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Internal Medicine. According to data from OpenAlex, Sven Nylander has authored 52 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 20 papers in Hematology and 19 papers in Internal Medicine. Recurrent topics in Sven Nylander's work include Antiplatelet Therapy and Cardiovascular Diseases (37 papers), Venous Thromboembolism Diagnosis and Management (19 papers) and Platelet Disorders and Treatments (17 papers). Sven Nylander is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (37 papers), Venous Thromboembolism Diagnosis and Management (19 papers) and Platelet Disorders and Treatments (17 papers). Sven Nylander collaborates with scholars based in Sweden, United States and United Kingdom. Sven Nylander's co-authors include Rainer Schulz, Marco Cattaneo, Hans Lennernäs, A.‐L. Ungell, Yumei Ye, Yochai Birnbaum, Timothy D. Warner, J.J.J. van Giezen, Carl Whatling and Christer Mattsson and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Sven Nylander

51 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sven Nylander Sweden 26 1.4k 569 544 431 415 52 2.6k
Atsuhiro Sugidachi Japan 19 1.7k 1.2× 515 0.9× 784 1.4× 174 0.4× 354 0.9× 64 2.2k
J.J.J. van Giezen Sweden 20 1.3k 0.9× 542 1.0× 441 0.8× 186 0.4× 369 0.9× 41 1.9k
Jean Combalbert France 12 778 0.5× 169 0.3× 309 0.6× 201 0.5× 120 0.3× 14 1.8k
Kathleen Butler United States 25 2.3k 1.6× 917 1.6× 1.0k 1.9× 108 0.3× 197 0.5× 67 3.1k
Zhongren Ding China 18 462 0.3× 182 0.3× 245 0.5× 386 0.9× 289 0.7× 40 1.6k
Uma Sinha United States 29 1.2k 0.8× 812 1.4× 242 0.4× 746 1.7× 743 1.8× 109 2.9k
Artur‐Aron Weber Germany 26 739 0.5× 251 0.4× 487 0.9× 539 1.3× 411 1.0× 61 2.4k
Marta Brambilla Italy 24 362 0.3× 159 0.3× 222 0.4× 424 1.0× 397 1.0× 78 1.8k
Giuseppe G. Nenci Italy 25 621 0.4× 433 0.8× 417 0.8× 265 0.6× 491 1.2× 100 1.9k
G. Defreyn Belgium 20 684 0.5× 244 0.4× 288 0.5× 289 0.7× 406 1.0× 34 1.7k

Countries citing papers authored by Sven Nylander

Since Specialization
Citations

This map shows the geographic impact of Sven Nylander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Nylander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Nylander more than expected).

Fields of papers citing papers by Sven Nylander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Nylander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Nylander. The network helps show where Sven Nylander may publish in the future.

Co-authorship network of co-authors of Sven Nylander

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Nylander. A scholar is included among the top collaborators of Sven Nylander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Nylander. Sven Nylander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Taylor S., Elizabeth J. Kelly, Sven Nylander, et al.. (2022). Serum levels of anti-PF4 IgG after AZD1222 (ChAdOx1 nCoV-19) vaccination. Scientific Reports. 12(1). 7961–7961. 5 indexed citations
2.
Johnston, S. Claiborne, Pierre Amarenco, Hans Denison, et al.. (2021). Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack. Stroke. 52(11). 3482–3489. 11 indexed citations
3.
4.
Löfgren, Lars, S. KENNETH PEHRSSON, Gunnar Hägglund, Henrik Tjellström, & Sven Nylander. (2018). Accurate measurement of endogenous adenosine in human blood. PLoS ONE. 13(10). e0205707–e0205707. 39 indexed citations
5.
Buduo, Christian A. Di, Eti Alessandra Femia, Robert F. Storey, et al.. (2016). Studies of the interaction of ticagrelor with the P2Y13 receptor and with P2Y13-dependent pro-platelet formation by human megakaryocytes. Thrombosis and Haemostasis. 116(12). 1079–1088. 14 indexed citations
6.
Nylander, Sven & Rainer Schulz. (2016). Effects of P2Y12 receptor antagonists beyond platelet inhibition – comparison of ticagrelor with thienopyridines. British Journal of Pharmacology. 173(7). 1163–1178. 89 indexed citations
7.
Teng, Rongyue, Glenn Carlson, Sven Nylander, & Tomas Andersson. (2016). Effects of autologous platelet transfusion on platelet inhibition in ticagrelor‐treated and clopidogrel‐treated subjects. Journal of Thrombosis and Haemostasis. 14(12). 2342–2352. 35 indexed citations
8.
Birnbaum, Yochai, et al.. (2016). Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine. Cardiovascular Drugs and Therapy. 30(6). 539–550. 43 indexed citations
9.
Nylander, Sven, S. KENNETH PEHRSSON, Tord Inghardt, et al.. (2015). A SPECIFIC ANTIDOTE FOR TICAGRELOR. Journal of the American College of Cardiology. 65(10). A253–A253. 1 indexed citations
10.
Nylander, Sven, et al.. (2015). Exploration of efficacy and bleeding with combined phosphoinositide 3‐kinase β inhibition and aspirin in man. Journal of Thrombosis and Haemostasis. 13(8). 1494–1502. 42 indexed citations
11.
Jeppsson, Anders, Sven Nylander, Anders Berggren, et al.. (2015). In vitro anti-platelet potency of ticagrelor in blood samples from infants and children. Thrombosis Research. 136(3). 620–624. 10 indexed citations
12.
Andersson, Tommy, et al.. (2014). Effect of Esomeprazole With/Without Acetylsalicylic Acid, Omeprazole and Lansoprazole on Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers. American Journal of Cardiovascular Drugs. 14(3). 217–227. 11 indexed citations
13.
Giordanetto, Fabrizio, et al.. (2014). Discovery of 9-(1-phenoxyethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as oral PI3Kβ inhibitors, useful as antiplatelet agents. Bioorganic & Medicinal Chemistry Letters. 24(16). 3936–3943. 19 indexed citations
14.
Cattaneo, Marco, Rainer Schulz, & Sven Nylander. (2014). Adenosine-Mediated Effects of Ticagrelor. Journal of the American College of Cardiology. 63(23). 2503–2509. 241 indexed citations
15.
Nylander, Sven, Eti Alessandra Femia, Mariangela Scavone, et al.. (2013). Ticagrelor inhibits human platelet aggregation via adenosine in addition to P2Y12 antagonism. Journal of Thrombosis and Haemostasis. 11(10). 1867–1876. 126 indexed citations
16.
Nylander, Sven, et al.. (2013). REVERSAL OF TICAGRELOR-INDUCED INHIBITION OF ADP-INDUCED PLATELET AGGREGATION BY THE ADDITION OF UNINHIBITED PLATELETS IN VITRO. Journal of the American College of Cardiology. 61(10). E214–E214. 1 indexed citations
17.
Gan, Li‐Ming, Ann Wittfeldt, Håkan Emanuelsson, Sven Nylander, & Jenny Jonasson. (2012). ADENOSINE MAY MEDIATE TICAGRELOR-INDUCED DYSPNEA. Journal of the American College of Cardiology. 59(13). E344–E344. 1 indexed citations
18.
Warner, Timothy D., Sven Nylander, & Carl Whatling. (2011). Anti‐platelet therapy: cyclo‐oxygenase inhibition and the use of aspirin with particular regard to dual anti‐platelet therapy. British Journal of Clinical Pharmacology. 72(4). 619–633. 175 indexed citations
19.
Nylander, Sven, Christer Mattsson, & Tomas Lindahl. (2005). Characterisation of species differences in the platelet ADP and thrombin response. Thrombosis Research. 117(5). 543–549. 32 indexed citations
20.
Bamberg, Krister, Sven Nylander, Kerstin G. Helander, et al.. (1994). In situ hybridization of mRNA for the gastric H+, K+-ATPase in rat oxyntic mucosa. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1190(2). 355–359. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atsuhiro Sugidachi Breakdown of academic impact, for papers by J.J.J. van Giezen Breakdown of academic impact, for papers by Jean Combalbert Breakdown of academic impact, for papers by Kathleen Butler Breakdown of academic impact, for papers by Zhongren Ding Breakdown of academic impact, for papers by Uma Sinha Breakdown of academic impact, for papers by Artur‐Aron Weber Breakdown of academic impact, for papers by Marta Brambilla Breakdown of academic impact, for papers by Giuseppe G. Nenci Breakdown of academic impact, for papers by G. Defreyn
Rankless by CCL
2026